Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-04-04
1987-12-01
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514210, 514219, 514234, 514248, 514250, 514257, 514278, 540203, 540353, 540492, 540493, 544 71, 544231, 546 18, A61K 31415, A61K 31305, C07D45500, C07D47120
Patent
active
047105046
ABSTRACT:
Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressants, antihypertensives, ocular antihypertensives, antidiabetics, platelet aggregation inhibitors, antiobesity agents, and modifiers of gastrointestinal motility.
Baldwin John J.
deSolms Jane
Guare, Jr. James P.
Huff Joel R.
Vacca Joseph P.
Jiles Henry R.
Merck & Co. , Inc.
Mullins J. G.
Nicholson William H.
Sudol Michael C.
LandOfFree
Anti-depressant spiro hexahydro arylquinolizine derivatives, com does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-depressant spiro hexahydro arylquinolizine derivatives, com, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-depressant spiro hexahydro arylquinolizine derivatives, com will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1931586